This bill amends section 499.0295 of the Florida Statutes to provide an exemption from public records requirements for certain information in the Department of Health's annual public report on experimental treatment outcomes and safety signals. Specifically, the bill designates health information and proprietary pricing information contained in the report as confidential and exempt from public disclosure under s. 119.07(1) and s. 24(a), Article I of the State Constitution. This change aims to protect sensitive personal health data of patients with terminal conditions or life-threatening rare diseases.

Additionally, the bill includes a statement of public necessity, asserting that the confidentiality of this information is crucial to prevent potential harm to patients. It emphasizes that patients pursuing experimental treatments have a strong expectation of privacy regarding their medical information, and the risks associated with disclosing such information outweigh any public benefits. The act is set to take effect contingent upon the passage of related legislation in the same session.